EURONEXT:ALTHX

Theranexus Société Anonyme

Stock

EUR

Last Close

0.50

12/11 16:35

Market Cap

7.44M

Beta: 2.11

Volume Today

20.64K

Avg: 7.41K

PE Ratio

−0.75

PFCF: −1.16

Overview Analysis Financials Filings people API Chart Data

locale
France
market
STOCKS
industry
Biotechnology
website
www.theranexus.com
ipo date
Oct 30, 2017

Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathi...Show More

EURONEXT:ALTHX

Theranexus Société Anonyme

Last Close

0.50

12/11 16:35

Market Cap

7.44M

Beta: 2.11

Volume Today

20.64K

Avg: 7.41K

PE Ratio

−0.75

PFCF: −1.16

locale

market

industry

website

ipo date

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics